Author:
Albanell Joan,Codony Jordi,Rovira Ana,Mellado Begoña,Gascón Pere
Reference71 articles.
1. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2:127–37.
2. Fendly BM, Winget M, Hudziak RM, Lipari MT, Napier MA, Ullrich A. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product. Cancer Res 1990; 50:1550–1558.
3. Carter P, Presta L, Gorman CM, et al. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc.Natl.Acad.Sci.USA 1992; 89:4285–4289.
4. Baselga J, Tripathy D, Mendelsohn J, et al. Phase II study of weekly intravenous recombinant humanized anti-pl851ER2monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J.Clin.Oncol 1996; 14:737–744.
5. Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the eficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. Journal of Clinical Oncology 2000; 17:2639–48.
Cited by
146 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献